Director General of NAFDAC, Professor Mojisola Adeyeye, stated that the agency’s vaccine committee has been assessing several vaccines despite the fact the vaccines have been approved by stringent regulatory countries or have received World Health Organisation (WHO)’s Emergency Use Listing (EUL). Adeyeye stressed that a COVID-19 vaccine that has gone through the prior approval from either of these two sources had gone through quality, safety and efficacy evaluation which is a prerequisite for acceptance by COVAX facility. She added that most regulatory agencies across the world use this mechanism to expedite their own regulatory approval to import and administer COVID-19 vaccines. “NAFDAC also gives full reviews for vaccines that have not gone through EUL route. “Each dose (0.5ml) contains 100 micrograms of messenger RNA (mRNA) (embedded in SM-102 lipid nanoparticles that serve as the delivery matrix).

Source: Nigerian Tribune July 15, 2021 12:33 UTC